跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RORyt
首页
药物
RORyt
RORyt
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
QUINOLINYL MODULATORS OF RORyt
US 2015111870 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
CN
US
2 件公开
Heteroaryl linked quinolinyl modulators of roryt
CN 104884448 A
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
CN
US
2 件公开
US 2014107097 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
US
ALKYL LINKED QUINOLINYL MODULATORS OF RORyt
US 2015105369 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
CN
US
2 件公开
COMPOUNDS AS RORyT MODULATORS AND USES THEREOF
US 2013065842 A1
申请人: LITTMAN DAN
优先权: 2011
US
AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF
US 2013085162 A1
申请人: LITTMAN DAN
优先权: 2011
US
US 2015057278 A1
申请人: LITTMAN DAN
优先权: 2012
US
STEROID COMPOUNDS AS RORyt MODULATORS AND USES THEREOF
US 2014066391 A1
申请人: LITTMAN DAN R
优先权: 2011
US
Secondary alcohol quinolinyl modulators of roryt
CN 105636952 A
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
CN
US 2015105372 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
US
METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt
US 2015105366 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
US
US 2014107094 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
US
PHENYL LINKED QUINOLINYL MODULATORS OF RORyt
US 2015105404 A1
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2013
US
Modulation of γδ T cells
US 10759863 B2
申请人: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
优先权: 2014
US
第 1 / 2 页
上一页
下一页
药物
反馈